UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma

British journal of cancer, 2014-07, Vol.111 (2), p.255-264

2014

Volltextzugriff (PDF)

Tyrosine kinase inhibitors gefitinib, lapatinib and sorafenib induce rapid functional alterations in breast cancer cells

Current cancer drug targets, 2010-06, Vol.10 (4), p.422-431

2010

Volltextzugriff (PDF)

Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients

Annals of oncology, 2011-10, Vol.22 (10), p.2294-2298

2011

Volltextzugriff (PDF)

c-kit and SCF expression in normal and tumor breast tissue

Breast cancer research and treatment, 2004, Vol.83 (1), p.33-42

2004

Volltextzugriff (PDF)

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines

Breast cancer research : BCR, 2005-01, Vol.7 (5), p.R681-R689, Article R681

2005

Volltextzugriff (PDF)

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL ( )

Leukemia, 2007-08, Vol.21 (8), p.1802-1811

2007

Volltextzugriff (PDF)

In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells

Current cancer drug targets, 2010-09, Vol.10 (6), p.600-610

2010

Volltextzugriff (PDF)

Efficacy of a nitric oxide–releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts

Molecular cancer therapeutics, 2006-04, Vol.5 (4), p.919-926

2006

Volltextzugriff (PDF)

Primary Cardiac Lymphoma: Report of Two Cases Occurring in Immunocompetent Subjects

Leukemia & lymphoma, 2004-04, Vol.45 (4), p.781-788

2004

Volltextzugriff (PDF)

Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma

Annals of oncology, 2008-07, Vol.19 (7), p.1331-1335

2008

Volltextzugriff (PDF)

Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer

British Journal of Cancer, 1999-10, Vol.81 (4), p.609-615

1999

Volltextzugriff (PDF)

In Vitro Schedule-dependent Interaction between Docetaxel and Gemcitabine in Human Gastric Cancer Cell Lines

Clinical cancer research, 2003-02, Vol.9 (2), p.900-905

2003

Volltextzugriff (PDF)

Phase II study of pegylated liposomal doxorubicin and oxaliplatin in relapsed advanced ovarian cancer

Gynecologic oncology, 2006-02, Vol.100 (2), p.318-323

2006

Volltextzugriff (PDF)

Schedule-Dependent Cytotoxic Interaction between Epidoxorubicin and Gemcitabine in Human Bladder Cancer Cells in Vitro

Clinical cancer research, 2004-02, Vol.10 (4), p.1500-1507

2004

Volltextzugriff (PDF)

In vitro preclinical models for a rational design of chemotherapy combinations in human tumors

Critical reviews in oncology/hematology, 2001, Vol.37 (1), p.69-82

2001

Volltextzugriff (PDF)

Role of biological markers in the clinical outcome of colon cancer

British journal of cancer, 2002-10, Vol.87 (8), p.868-875

2002

Volltextzugriff (PDF)

Detection of Colorectal Cancer by a Quantitative Fluorescence Determination of DNA Amplification in Stool

Neoplasia (New York, N.Y.), 2004-09, Vol.6 (5), p.536-540

2004

Volltextzugriff (PDF)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

BMC cancer, 2006-03, Vol.6 (1), p.76-76, Article 76

2006

Volltextzugriff (PDF)

Modulation of drug cytotoxicity by iressa (ZD1839) in pancreatic cancer cell lines

Cancer biology & therapy, 2005-10, Vol.4 (10), p.1089-1095

2005

Volltextzugriff (PDF)

Role of p53 Codon 72 Arginine Allele in Cell Survival in vitro and in the Clinical Outcome of Patients with Advanced Breast Cancer

Tumor biology, 2008-01, Vol.29 (3), p.145-151

2008

Volltextzugriff (PDF)

In Vitro Schedule-dependent Interactions between the Multitargeted Antifolate LY231514 and Gemcitabine in Human Colon Adenocarcinoma Cell Lines

Clinical cancer research, 2002-01, Vol.8 (1), p.233-239

2002

Volltextzugriff (PDF)

Schedule‐dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines

International journal of cancer, 1999-01, Vol.80 (3), p.413-416

1999

Volltextzugriff (PDF)

Phase I Study of Paclitaxel and Uracil plus Tegafur Combination in Patients with Pretreated Metastatic Breast Cancer: Drug Sequencing Based on Preclinical Modelling Studies

Oncology, 2007-01, Vol.72 (1-2), p.118-124

2007

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(51)
Science & Technology
(51)
Humans
(50)
Female
(36)
Biological And Medical Sciences
(32)
Medical Sciences
(30)
Middle Aged
(27)
Aged
(21)
Adult
(20)
Male
(18)
Antineoplastic Agents
(16)
Pharmacology. Drug Treatments
(16)
Breast Neoplasms - Pathology
(14)
Tumor Cells, Cultured
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Breast Neoplasms - Drug Therapy
(12)
Chemotherapy
(11)
Tumors
(11)
Doxorubicin - Administration & Dosage
(9)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma

Tyrosine kinase inhibitors gefitinib, lapatinib and sorafenib induce rapid functional alterations in breast cancer cells

Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients

c-kit and SCF expression in normal and tumor breast tissue

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines

Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL ( )

In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells

Efficacy of a nitric oxide–releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts

Primary Cardiac Lymphoma: Report of Two Cases Occurring in Immunocompetent Subjects

Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma

Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer

In Vitro Schedule-dependent Interaction between Docetaxel and Gemcitabine in Human Gastric Cancer Cell Lines

Phase II study of pegylated liposomal doxorubicin and oxaliplatin in relapsed advanced ovarian cancer

Schedule-Dependent Cytotoxic Interaction between Epidoxorubicin and Gemcitabine in Human Bladder Cancer Cells in Vitro

In vitro preclinical models for a rational design of chemotherapy combinations in human tumors

Role of biological markers in the clinical outcome of colon cancer

Detection of Colorectal Cancer by a Quantitative Fluorescence Determination of DNA Amplification in Stool

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Modulation of drug cytotoxicity by iressa (ZD1839) in pancreatic cancer cell lines

Role of p53 Codon 72 Arginine Allele in Cell Survival in vitro and in the Clinical Outcome of Patients with Advanced Breast Cancer

In Vitro Schedule-dependent Interactions between the Multitargeted Antifolate LY231514 and Gemcitabine in Human Colon Adenocarcinoma Cell Lines

Schedule‐dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines

Phase I Study of Paclitaxel and Uracil plus Tegafur Combination in Patients with Pretreated Metastatic Breast Cancer: Drug Sequencing Based on Preclinical Modelling Studies

Aktive Filter

Suchergebnisse filtern